About three months ago, Hemo Times reported that there were 53 reported Hemlibra deaths. Well, the FDA Adverse Events Reporting System (FAER

Hemo Times has launched its mobile application. The app is now available for both Apple and Android devices.

Bayer, the pharma company that killed thousands of hemophiliacs in the late ’70s and early ’80s when they released factor that was...

Below you will find a current list of Hemophilia A products along with their death and adverse reactions data. By looking at this data, em

What is pharmacovigilance? All the activities involved in detecting, checking and understanding the harmful effects of the drugs and prevent

Back in September, we published a story about Hemo Times founder, Jesse John Francis Clark, getting kicked out of his local HTC for...

The Hemo Times app will be launching on both Apple and Android app stores next month. Once the Hemo Times app is live, we will no longer...

According to the Federal Adverse Events Reporting System (FAERS) there are now 54 deaths involving the use of Emicizumab a/k/a Hemlibra....

A community member contacted Hemo Times yesterday out of frustration with Navicent Health’s dealing with a newborn infant born with...

You probably saw the article that was posted yesterday where I introduced you to news of 800 Massachusetts nurses that are on strike....

There are currently 800 or so nurses on strike at Saint Vincent Hospital located in Worcester, Massachusetts.

As pharmaceutical companies make unprecedented progress on the production of COVID-19 vaccines with the end goal of vaccinating the...

According to the FDA Adverse Events Reporting System, we can see that there are now 47 deaths for patients who were perscribed Hemliba....

Bleeding Disorder Non-profit HemoAware merges with Hemo Times

While being active in the bleeding disorders community, we get to see and hear everything. The bleeding disorders community is a small...

Amber Federizo is Now Under Investigation by Nevada State Board of Nursing

Sanofi Genzyme had placed a global dosing hold on its “full clinical development program for fitusiran due to the identification of new...

Kickbacks are fraudulent and threaten the quality of care of hemophilia patients. Even though the government has enacted laws to deter and s

Hemo Times has learned that Genentech will no longer publish quaterly data on hemlibra deaths. HemoAware Founder, Jesse John Francis Clark,

On September 25, 2020, Pomerantz LLP filed a class action against BioMarin for making materially false and misleading statements...